Logo image of MAS

MASCO CORP (MAS) Stock Fundamental Analysis

USA - NYSE:MAS - US5745991068 - Common Stock

72.99 USD
+0.52 (+0.72%)
Last: 9/18/2025, 8:04:00 PM
72.99 USD
0 (0%)
After Hours: 9/18/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, MAS scores 5 out of 10 in our fundamental rating. MAS was compared to 41 industry peers in the Building Products industry. MAS has an average financial health and profitability rating. MAS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MAS was profitable.
In the past 5 years MAS has always been profitable.
Each year in the past 5 years MAS had a positive operating cash flow.
MAS Yearly Net Income VS EBIT VS OCF VS FCFMAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

The Return On Assets of MAS (15.22%) is better than 90.24% of its industry peers.
The Return On Invested Capital of MAS (27.94%) is better than 97.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MAS is significantly above the industry average of 12.76%.
Industry RankSector Rank
ROA 15.22%
ROE N/A
ROIC 27.94%
ROA(3y)16.52%
ROA(5y)15.57%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)29.73%
ROIC(5y)29.08%
MAS Yearly ROA, ROE, ROICMAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

Looking at the Profit Margin, with a value of 10.51%, MAS is in the better half of the industry, outperforming 60.98% of the companies in the same industry.
In the last couple of years the Profit Margin of MAS has declined.
Looking at the Operating Margin, with a value of 17.55%, MAS is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
In the last couple of years the Operating Margin of MAS has remained more or less at the same level.
Looking at the Gross Margin, with a value of 36.25%, MAS is in line with its industry, outperforming 56.10% of the companies in the same industry.
In the last couple of years the Gross Margin of MAS has remained more or less at the same level.
Industry RankSector Rank
OM 17.55%
PM (TTM) 10.51%
GM 36.25%
OM growth 3Y0.19%
OM growth 5Y1.26%
PM growth 3Y29.39%
PM growth 5Y-5.39%
GM growth 3Y1.89%
GM growth 5Y0.46%
MAS Yearly Profit, Operating, Gross MarginsMAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

MAS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MAS has been reduced compared to 1 year ago.
Compared to 5 years ago, MAS has less shares outstanding
MAS has a worse debt/assets ratio than last year.
MAS Yearly Shares OutstandingMAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
MAS Yearly Total Debt VS Total AssetsMAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 4.13 indicates that MAS is not in any danger for bankruptcy at the moment.
With a Altman-Z score value of 4.13, MAS perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 4.13
ROIC/WACC2.84
WACC9.82%
MAS Yearly LT Debt VS Equity VS FCFMAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

MAS has a Current Ratio of 1.82. This is a normal value and indicates that MAS is financially healthy and should not expect problems in meeting its short term obligations.
MAS's Current ratio of 1.82 is in line compared to the rest of the industry. MAS outperforms 43.90% of its industry peers.
MAS has a Quick Ratio of 1.14. This is a normal value and indicates that MAS is financially healthy and should not expect problems in meeting its short term obligations.
MAS's Quick ratio of 1.14 is in line compared to the rest of the industry. MAS outperforms 46.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.14
MAS Yearly Current Assets VS Current LiabilitesMAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

MAS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.55%.
Measured over the past years, MAS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.05% on average per year.
MAS shows a decrease in Revenue. In the last year, the revenue decreased by -2.73%.
MAS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.14% yearly.
EPS 1Y (TTM)4.55%
EPS 3Y3.57%
EPS 5Y10.05%
EPS Q2Q%8.33%
Revenue 1Y (TTM)-2.73%
Revenue growth 3Y-2.23%
Revenue growth 5Y3.14%
Sales Q2Q%-1.91%

3.2 Future

Based on estimates for the next years, MAS will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.29% on average per year.
MAS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y-1.91%
EPS Next 2Y3.62%
EPS Next 3Y6.51%
EPS Next 5Y9.29%
Revenue Next Year-2.72%
Revenue Next 2Y0.2%
Revenue Next 3Y1.47%
Revenue Next 5Y4.43%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MAS Yearly Revenue VS EstimatesMAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MAS Yearly EPS VS EstimatesMAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.63 indicates a rather expensive valuation of MAS.
MAS's Price/Earnings ratio is a bit cheaper when compared to the industry. MAS is cheaper than 65.85% of the companies in the same industry.
When comparing the Price/Earnings ratio of MAS to the average of the S&P500 Index (27.41), we can say MAS is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.58 indicates a correct valuation of MAS.
65.85% of the companies in the same industry are more expensive than MAS, based on the Price/Forward Earnings ratio.
MAS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 17.63
Fwd PE 16.58
MAS Price Earnings VS Forward Price EarningsMAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

MAS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MAS is cheaper than 63.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.89
MAS Per share dataMAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The decent profitability rating of MAS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.75
EPS Next 2Y3.62%
EPS Next 3Y6.51%

6

5. Dividend

5.1 Amount

MAS has a Yearly Dividend Yield of 1.65%.
MAS's Dividend Yield is rather good when compared to the industry average which is at 1.13. MAS pays more dividend than 90.24% of the companies in the same industry.
MAS's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

On average, the dividend of MAS grows each year by 18.34%, which is quite nice.
MAS has been paying a dividend for at least 10 years, so it has a reliable track record.
MAS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)18.34%
Div Incr Years11
Div Non Decr Years14
MAS Yearly Dividends per shareMAS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

15.65% of the earnings are spent on dividend by MAS. This is a low number and sustainable payout ratio.
MAS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP15.65%
EPS Next 2Y3.62%
EPS Next 3Y6.51%
MAS Yearly Income VS Free CF VS DividendMAS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MAS Dividend Payout.MAS Dividend Payout, showing the Payout Ratio.MAS Dividend Payout.PayoutRetained Earnings

MASCO CORP

NYSE:MAS (9/18/2025, 8:04:00 PM)

After market: 72.99 0 (0%)

72.99

+0.52 (+0.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners96.81%
Inst Owner Change-0.03%
Ins Owners0.16%
Ins Owner Change1.28%
Market Cap15.28B
Analysts69.63
Price Target76.76 (5.17%)
Short Float %2.83%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Yearly Dividend1.17
Dividend Growth(5Y)18.34%
DP15.65%
Div Incr Years11
Div Non Decr Years14
Ex-Date08-08 2025-08-08 (0.31)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.11%
Min EPS beat(2)-6.26%
Max EPS beat(2)18.48%
EPS beat(4)2
Avg EPS beat(4)2.93%
Min EPS beat(4)-6.26%
Max EPS beat(4)18.48%
EPS beat(8)6
Avg EPS beat(8)6.28%
EPS beat(12)8
Avg EPS beat(12)8.11%
EPS beat(16)10
Avg EPS beat(16)6.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-2.91%
Max Revenue beat(2)1.89%
Revenue beat(4)1
Avg Revenue beat(4)-1.01%
Min Revenue beat(4)-2.91%
Max Revenue beat(4)1.89%
Revenue beat(8)2
Avg Revenue beat(8)-0.48%
Revenue beat(12)4
Avg Revenue beat(12)-0.36%
Revenue beat(16)7
Avg Revenue beat(16)0.42%
PT rev (1m)0%
PT rev (3m)6.72%
EPS NQ rev (1m)2.62%
EPS NQ rev (3m)17.82%
EPS NY rev (1m)11.81%
EPS NY rev (3m)12.56%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-0.3%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 17.63
Fwd PE 16.58
P/S 1.99
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.89
EPS(TTM)4.14
EY5.67%
EPS(NY)4.4
Fwd EY6.03%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS36.6
BVpS-0.4
TBVpS-4.41
PEG (NY)N/A
PEG (5Y)1.75
Profitability
Industry RankSector Rank
ROA 15.22%
ROE N/A
ROCE 36.56%
ROIC 27.94%
ROICexc 31.25%
ROICexgc 41.97%
OM 17.55%
PM (TTM) 10.51%
GM 36.25%
FCFM N/A
ROA(3y)16.52%
ROA(5y)15.57%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)29.73%
ROIC(5y)29.08%
ROICexc(3y)35.59%
ROICexc(5y)37.39%
ROICexgc(3y)51.43%
ROICexgc(5y)55.89%
ROCE(3y)38.9%
ROCE(5y)38.06%
ROICexcg growth 3Y-6.31%
ROICexcg growth 5Y4.48%
ROICexc growth 3Y-3.35%
ROICexc growth 5Y4.14%
OM growth 3Y0.19%
OM growth 5Y1.26%
PM growth 3Y29.39%
PM growth 5Y-5.39%
GM growth 3Y1.89%
GM growth 5Y0.46%
F-ScoreN/A
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.97
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.14
Altman-Z 4.13
F-ScoreN/A
WACC9.82%
ROIC/WACC2.84
Cap/Depr(3y)143.19%
Cap/Depr(5y)119.76%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.18%
Profit Quality(3y)104.12%
Profit Quality(5y)115.79%
High Growth Momentum
Growth
EPS 1Y (TTM)4.55%
EPS 3Y3.57%
EPS 5Y10.05%
EPS Q2Q%8.33%
EPS Next Y-1.91%
EPS Next 2Y3.62%
EPS Next 3Y6.51%
EPS Next 5Y9.29%
Revenue 1Y (TTM)-2.73%
Revenue growth 3Y-2.23%
Revenue growth 5Y3.14%
Sales Q2Q%-1.91%
Revenue Next Year-2.72%
Revenue Next 2Y0.2%
Revenue Next 3Y1.47%
Revenue Next 5Y4.43%
EBIT growth 1Y-1.1%
EBIT growth 3Y-2.04%
EBIT growth 5Y4.44%
EBIT Next Year5.06%
EBIT Next 3Y5.67%
EBIT Next 5Y7.56%
FCF growth 1Y-22.48%
FCF growth 3Y4.19%
FCF growth 5Y6.21%
OCF growth 1Y-23.92%
OCF growth 3Y4.95%
OCF growth 5Y5.23%